This is the way it should be. The FDA has called for more testing on an obesity drug because of previous effects of other weightloss drugs. Although there are opponents that claim that this will give a huge incentive to not creating obesity drugs, it is definently worth more testing in order to validate its safety. I can see why people really want more drugs because 1/3 of American adults are obese, but extra precautions are good. The past has shown us that similar drugs affected the heart, and cardiovascular system.
Written by Jonathan Chang